Drug and Alcohol Dependence

Article	Citations
EFFECTS OF SOCIAL DEFEAT STRESS EXPOSURE ON SPATIAL MEMORY PERFORMANCE IN SOCIALLY MONOGAMOUS MALE PRAIRIE VOLES	287
EXPLORING ASSOCIATIONS BETWEEN TRADITIONAL GENDER NORMS AND PRE-IMMIGRATION SEXUAL RISK BEHAVIORS AMONG MALE & FEMALE RECENT LATINO/A IMMIGRANTS	162
SEX AND GENOTYPE DEPENDENT DRUG-INDUCED DOPAMINE RELEASE IN ADOLESCENT CHRNA6 3’-UTR RATS	128
Drug use and needle sharing among adolescents and young adults in Nigeria: A cross-sectional secondary analysis of data from a multi-site clinical trial	117
Comparing Racial and Ethnic Differences on Access to Wellness Services for People in Substance Use Treatment	82
Receiving Medications for Opioid Use Disorder in Maryland Correctional Facilities and at a Community-Based Low-Threshold Buprenorphine Program Post-Release: Patient and Staff Perspectives	78
Sex Differences in Contextual Cocaine Seeking Behavior are Driven by Noradrenergic Signaling to the Dorsal Hippocampus	68
UTILIZING INNOVATIVE APPROACHES TO ENHANCE THE FULL POTENTIAL OF SUBSTANCE USE DATA TO BENEFIT MINORITIZED POPULATIONS	63
Misuse Potential of Medicinal Ketamine in Real-World Clinical Contexts, Part 1: Patients With At-Home Prescribed Ketamine	57
Risky Polysubstance Use Among People who Use Opioids in a Community-Based Study	55
Clinical Translation of the HR/LR Model of SUD Propensity	54
Guanfacine Reduces Drug Craving, Stress and Increases the Number of Abstinence Days in Women With Polysubstance Use Disorder (PSUD): A Pilot 2-Site Clinical Study	54
BRIDGING THE GAP: PRACTICAL AND ETHICAL CONSIDERATIONS ON THE UTILITY OF ARTIFICIAL INTELLIGENCE IN SUBSTANCE USE DISORDERS	53
Evaluation of Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use via Ecological Momentary Assessments	52
Provider Perspectives on Child Protective Services Reporting for Perinatal Patients With Opioid Use Disorder	51
Beyond Rest: Unraveling the Nexus of Sleep Deficiency, Environment, Control, and their Influence on Opioid Use Disorder Treatment Outcomes	50
The Association between Poly-victimization and Opioid Misuse Among Justice-Involved Adolescents	49
Adolescent Gender Diversity and Substance Use Exposure: A Mediating Role of Peer Victimization	49
Characterizing Substance Use Disorder on Reddit Through Network Analysis and Transitions of Use Between Opioids, Cannabis, and Other Drugs	47
Chronic Oral Dosing of Cannabidiol (CBD) With and Without low Doses of Delta-9-Tetrahydrocannabinol (Δ-9-THC)	42
The Effects of Acupuncture Stimulation at Shenmen (HT7) on Brain Stimulation Reward in Rats	42
A randomized pilot trial of two forms of behavioral economics intervention to improve engagement in buprenorphine-naloxone treatment among patients with opioid use disorder	42
Development of the Subject-Rated Comprehensive Drug Withdrawal Scale (CDWS) to Evaluate the Physical Dependence Potential of Investigational Drugs	40
Racial and Ethnic Disparities in Telehealth and Emergency Department Use Among Women With Substance Use Disorder during the COVID-19 Pandemic	39
A Comparative Study of Behavioral Effects of Novel Designer Drugs in Male Rodents	39

Factors Associated With Self-Directed Discharge Among Hospitalized Individuals With a Substance Use Disorder	38
Determination of Yohimbine's Reinforcing Actions in Male and Female Rats	37
Denial of Prescription Pain Medication Among People Who Use Drugs in Vancouver, Canada	36
Nalfurafine is Aversive at Analgesic Doses - Non-Clinical Evidence to Indicate It is Not an Atypical Kappa Opioid Receptor Agonist	35
Comparative Effectiveness of Intranasal Naloxone and Nalmefene in a Translational Model Assessing Reversal of Cardiac Arrest Induced by Synthetic Opioid Overdose	35
Risk of COVID-19 Hospitalization and Death in Patients on Chronic Opioid Therapy and With Opioid Use Disorder	34
Pharmacology of Newer Synthetic Cannabinoids at the CB1 Receptor	34
Screening in Trauma for Opioid Misuse Prevention (STOMP): Results from a prospective cohort of victims of traumatic injury	33
Assessment of the Publication Trends of the Harm Reduction Studies over 40 Years	33
The moderating role of resilience in the relationship between experiences of COVID-19 response-related discrimination and disinformation among people who inject drugs	33
Editorial Board	33
Letter to the Editor regarding: Is implementation of ASAM-based addiction treatment assessments associated with improved 30-day retention and substance use? (By Mark et al., 2021)	32
Editorial Board	32
Impact of the Russian invasion on opioid agonist therapy programs in Ukraine: A qualitative study	32
Neighborhood disadvantage and prescription drug misuse in low-income urban mothers	31
A novel long-acting formulation of oral buprenorphine/naloxone produces prolonged decreases in fentanyl self-administration by rhesus monkeys	31
Corrigendum to “Longitudinal latent class analysis of tobacco use and correlates among young adults over a 10-year period” [Drug Alcohol Depend. 236 (2022) 109474]	31
Use of laboratory data for illicit drug use surveillance and identification of socioeconomic risk factors	31
Access to methadone clinics and opioid overdose deaths in Georgia: A geospatial analysis	31
Cannabis use and subjective response to alcohol in the human laboratory	31
Generational shifts in attitudes and beliefs about alcohol: An age-period-cohort approach	30
Development and validation of the Schedule for the Assessment of Insight in Alcohol Dependence (SAI-AD): Dimensions and correlates of insight in alcohol use disorder	30
Pilot randomized trial of cognitive-behavioral treatment plus contingency management for quitting smoking and weight gain prevention among smokers with overweight or obesity	29
Avoidance of Racial Trauma Exposure and Concurrent Substance Use Among Racial/Ethnic Minoritized Young Adults	29
Social addiction or nicotine addiction? The effect of smoking social motivation on inhibitory control under smoking social cues: Evidence from ERPs	29
Longitudinal patterns of opioid and stimulant use by route of administration among people who inject drugs in the South Atlantic Fentanyl Test Strip Study: A latent transition analysis	29
Genetic Insights into the causal relationship between cannabis use and diabetic phenotypes: A genetic correlation and Mendelian randomization study	29
A Pilot Study of 16-Week Intensive Outpatient Treatment for Gay and Bisexual Men With Methamphetamine Use Disorder in Taiwan	29
Preferences for Abstinence-Based Recovery and Public Stigma Toward Substance Use	28
TERPENE AND CANNABINOID PROFILE PREFERENCES AND CANNABIS USE PRACTICES IN MEDICAL CANNABIS PATIENTS WHO USE CANNABIS FOR PAIN AND ANXIETY	28
More Stress Than You Know: A Qualitative Study of Client Experiences Navigating MOUD Treatment	28
XYLAZINE: AN ADULTERANT DRUG OF CONCERN	28
A Novel Hand-Held Personalized Dual Biometrically Controlled Device for At-Home Dispensation of Methadone	27
Perceived Stigma on the Emotional Wellbeing Among Latinx With Substance Use Disorders: The Mediated Roles of Self-Stigma and Self-Efficacy	27
How Common is Fentanyl Contamination of Methamphetamine? Attitudes, Self-Reported Exposures, and Toxicology Data From Persons who Use Methamphetamine	27
A Novel 3mg Naloxone Nasal Spray for the Over-the-Counter Market	26
Effects of access condition on substance use disorder-like phenotypes in male and female rats self-administering MDPV or cocaine	26
Treatment Engagement, Cigarette Smoking, and Quit Attempts one Month After a Randomized Controlled Trial of E-Cigarette Reduction Among Dual Users	26
SYMPOSIUM: 10 YEARS GONE: REMEMBERING BILL WOOLVERTON THROUGH HIS IMPACT ON OUR CURRENT RESEARCH PROGRAMS	26
Associations between right inferior frontal gyrus morphometry and inhibitory control in individuals with nicotine dependence	26
Ethical and Methodological Challenges in Studying Discontinuation of Medications for Opioid Use Disorder	26
Post-Stress Late Positive Potential Prospectively Predicts Cannabis Use Disorder Severity in Cannabis Using Women	26
Worsening trends in the frequency of methamphetamine and other stimulant use between treatment admission and discharge	26
Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis	25
The opioid epidemic in rural communities: Can telehealth increase access to medications for opioid use disorder and offset barriers to care?	25
Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016–17	25
Ethnic density effect on alcohol-related hospitalizations among Chinese enclaves and ethnoburbs in California, 2007–2011	25
Substance-induced mental disorders and discontinuation of medication for opioid use disorder	25
Punishment of ethanol choice in group-housed male cynomolgus monkeys	25
Trajectories of neighborhood-level overdose risk predictions for prioritization of harm reduction services: Results from the PROVIDENT study	25

The centrality of craving in network analysis of five substance use disorders	25
Does substance use disorder treatment completion reduce the risk of treatment readmission in Chile?	24
Relationship perceptions and conflict behavior among cannabis users	24
Polysubstance use in pregnancy: Findings from a population-based cross-sectional cohort study of pregnant women with opioid use	24
Reduced neural functional connectivity during working memory performance in methamphetamine use disorder	24
VAGINAL INSTABILITY AND DYSBIOSIS IS PREVALENT AMONG HISPANIC WOMEN LIVING IN PUERTO RICO REGARDLESS OF BODY MASS INDEX	23
Types of criminal legal system exposure and polysubstance use: Prevalence and correlates among U.S. adults in the National Survey on Drug Use and Health, 2015–2019	23
CHARACTERIZING MULTISYSTEM STIGMA: EXAMINING ITS ADVERSE IMPACT ON MOTHERS' ENGAGEMENT AND RETENTION IN RESIDENTIAL SUD TREATMENT	23
CULTURALLY RESPONSIVE TRAINING TO PRACTITIONERS: REDUCING MENTAL HEALTH DISPARITIES AMONG HISPANIC AND LATINOS	23
Health care provider decision-making around prenatal substance use reporting	23
Methodological considerations when assessing symptoms of nicotine dependence by cigarette and e-cigarette use behavior and brand	23
Exploring the relationship between sleep disturbances and cannabis use outcomes among Hispanic/Latino young adults	23
Rising opioid-associated skin and soft tissue infections and the emerging threat of xylazine: A national analysis	23
Examining the effect of prescription drug monitoring program integration and mandatory use policies on the distribution of methadone and buprenorphine for opioid use disorder, United States, 2009–2021	22
Characterizing Online Questions and Answers about Cannabis Use and Pregnancy: Data Mining and Content Analysis on the Social Media Platform Quora	22
Qualitative Exploration of Opioid Overdose Response Steps Among Women Who Use Drugs on the Rural Eastern Shore of Maryland	22
Why Do Medical Cannabis Patients use Illicit Medicinal Cannabis in the State of Utah?	22
Impact of the Sudden Closure of Mexico’s Only Methadone Manufacturing Plant on the Mental, Financial and Social Health of Patients With Opioid Use Disorder (OUD) in Tijuana, Mexico	22
Associations Between Interoceptive Control of Avoidance and Patterns of Morphine Self-Administration	22
Provision of Recovery Support Services in Opioid Use Disorder (OUD) Treatment Settings: A Secondary Data Analysis of the National Survey of Substance Abuse Treatment Services (N-SSATS) Data	22
Experiential Smoking Urges and Nicotine Withdrawal Reduction Among People Under Community Corrections Supervision Enrolled in In Vivo NRT Counseling	22
A Qualitative Analysis of Individual, Relationship, and Community Factors Influencing Non-Initiation of Medications for Opioid Use Disorder During Incarceration	21
Racialized Differences in the Prevalence of Drug Use Disorder Among Transgender Veterans	21
“I Feel like People Would Look at Me like I’m Dirty or like I’m a Thief:” a Qualitative Exploration of Internal Experiences that Influence Recovery Among Adults at Risk of Opioid-Related Overdose	21
Perceptions of Cannabis and its Associations With Mental Health Amongst Budtenders in Southern Ontario	21
Liver Disease Among People who Inject drugs: A Prospective Longitudinal Cohort Study Linked to Administrative Hospital Data	21
Within-Subject Evaluation of Technology-Assisted Buprenorphine Treatment	21
“Icy” Flavor Components in E-cigarette Images: Influence on Liking and Intention to Use Among Youth Who are Susceptible to E-cigarette Use	21
Conducting Community-Based Research on Substance Use in Rural Canada: Ethical and Methodological Considerations for Future Research	21
In Vivo Imaging Evidence of a Neuroinflammatory Phenotype Among Patients With Opioid Use Disorder	20
Depression Outcomes Among Women Participating in Worth Transitions	20
Legality of drug checking equipment in the United States: A systematic legal analysis	20
The relationship between co-use of tobacco and alcohol and cognitive decline in middle-aged and older Chinese males: A cross-lagged panel network analysis	20
Rates of Medication Prescription, Mental Health Disorder, and HCV Diagnoses Among Patients With Comorbid Alcohol and Opioid Use Disorder in Rural Primary Care Clinics	20
Maryland Opioid Overdose Deaths From 2018 to 2021: Occupational Pattern and Its Sociodemographic Variations	20
Editorial Board	20
Who Gets Treatment And Who Gets Criminalized Racialized Associations Between Cannabis Arrests And Criminal Legal System Referrals To Cannabis Treatment, 1992-2019	20
Characterizing Empirically-Derived Sub-Groups of Latinx PWID Living Along the U.S.-Mexico Border for HIV and HCV Prevention	20
Tobacco use is associated with low peripheral beta-arrestin 1 levels in major depression: A preliminary report	20
Pharmacist Involvement in Motivational Interviewing Intervention for Patients with Prescription Opioid Misuse Behaviors	20
Dose by design: How limits on nicotine flux and puff duration affect the abuse liability of electronic nicotine delivery systems	20
Outpatient initiation of direct-to-inject buprenorphine	20
NIAAA Update Presented by George Koob, Director of the National Institute on Alcohol Abuse and Alcoholism	20
SUVOREXANT, AN FDA-APPROVED DUAL OREXIN RECEPTOR ANTAGONIST, EFFECTIVELY REDUCES OXYCODONE SELF-ADMINISTRATION AND CONDITIONED REINSTATEMENT IN MALE AND FEMALE RATS	19
DEPRESSION SCREENING AMONG PERINATAL PATIENTS WITH AND WITHOUT SUBSTANCE USE DISORDERS FOLLOWING IMPLEMENTATION OF A COLLABORATIVE CARE PROGRAM	19
Syndemic Profiles and Opioid-Related Mortality Among People Initiating Chronic Episodes of Prescription Opioid Use in BC, Canada	19
GABAPENTIN UTILIZATION AMONG BUPRENORPHINE-PRESCRIBED INDIVIDUALS WITH OPIOID USE DISORDER AND ASSOCIATED RISK OF OVERDOSE	19
RECENT INCARCERATION, SUBSTANCE USE, OVERDOSE, AND TREATMENT AMONG RURAL PEOPLE WHO USE DRUGS	19
Brandeis/Harvard Spire Center: SUD Systems Performance Improvement Research and Engagement	19
THE FAMILIAR TASTE OF POISON: A QUALITATIVE STUDY OF MULTI-LEVEL MOTIVATIONS FOR STIMULANT USE IN SEXUAL MINORITY MEN LIVING IN SOUTH FLORIDA	19
Perceptions of Racism’s Impact on Drug Use Among African Americans Using Opioids	19
Domestic Cannabis Cultivation: Results of the Georgian (country) Sample of the Transnational Online Survey of Cannabis Growers	19
Performance of a Brief Substance Use Symptom Checklist (SUSC) for Identifying Substance Use Disorder Among Primary Care Patients With or at Elevated Risk for Opioid Use Disorder	18
Primary Form of Cannabis Use and Recent Negative Affect Symptoms	18
Common and Distinct Associations Between Baseline Impulsivity and Longitudinal Development of Positive and Negative Alcohol Expectancies in the Adolescent Brain Cognitive Development (ABCD) Cohort	18
Substance Co-Exposure Among Women With Opioid Use During Pregnancy	18
Psychosocial and Drug Use Characteristics in Persons With Opioid Use Disorder and Chronic Pain	18
Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial	18
Sex Differences in the Prospective Association of Intra-Individual Reaction Time Variability in Stroop and Hazardous Cannabis Use at Six Months	17
Self-Perception of Smoking Status and Co-Use of Cannabis and Narcotic Pain Medication	17
Treatment Outcomes From Computerized CBT for Substance Use Disorders Among People With Criminal Justice Involvement	17
Disparities in the Hepatitis C Virus Cascade of Care Among Reproductive Age Women With Opioid Use Disorder	17
Cannabis Use Effects on Reaction Time in Daily Versus Occasional Users	17
Outcomes of the Community-Based Medication-First Program for Opioid Use Disorder: A Multisite Hybrid Implementation Study	17
Characterization of Peer Support Services for Substance Use Disorders in 11 U.S. Emergency Departments in 2020: Findings From a Nida Clinical Trials Network Study Site Selection Process	17
Optimizing Recovery Funding: Barriers to Acquiring Funding Among Organizations in the Ecosystem of Recovery	17
Barriers and Facilitators to Injectable Opioid Agonist Treatment Engagement: A Qualitative Study of Patient Experiences in Vancouver, Canada	16
Modeling cue-exposure therapy for alcohol use disorder in rhesus monkeys: Effects of putative cognitive enhancers	16
“I still partly think this is bullshit”: A qualitative analysis of cannabinoid hyperemesis syndrome perceptions among people with chronic cannabis use and cyclic vomiting	16
Modes of Cannabis Administration and Their Associations With Binge Drinking Among 12th Grade Students in the United States: A Cross-Sectional Analysis from 2018-2021	16
SUBSTANCE USE DISORDERS AND ASSOCIATED MEDICAL CONSEQUENCES: IMPLICATIONS FOR PREVENTION AND TREATMENT	16
Sex Differences in Lifetime Non-Medical Prescription Opioid and Cannabis Use Among Older Adults in the All of Us Research Program	16
Behavioral and Psychosocial Predictors of Cannabis Use Among Youth During the COVID-19 Pandemic	16
The defining characteristic of substance use disorders	16
Oral Oxycodone Self Administration in Rats With a History of Responding under a Multiple Schedule for Ethanol and Food or Oxycodone and Food	16
Pregnancy Rates Among Women Treated With Medication for Opioid Use Disorder	16
Beyond Euphoria: Transcriptomic Investigation in the rat Brain Under the Administration of Fentanyl Combined With Xylazine	16
Mental Health Care Barriers for Women Involved in the Criminal Legal System With Substance Use Disorders: A Qualitative Study	16
Methodology for Single- vs Polydrug Classification of Poisoning Deaths	16
MEDIA FORUM	16

Naloxone Stigma Among People With Substance Use Disorder: Characteristics and Associations With Stigma toward Medication for Opioid Use Disorder (MOUD)	16
Prevalence and socio-structural determinants of tobacco exposure in young women: Data from the Healthy Trajectories Initiative (HeLTI) study in urban Soweto, South Africa	16
APP-BASED CONTINGENCY MANAGEMENT TO REDUCE HEAVY DRINKING DAYS AMONG SMOKERS RECEIVING VARENICLINE: FINDINGS FROM A WITHIN-SUBJECT A-B-A DESIGN TRIAL	16
The Association Between Sleep Health and Multiple Tobacco Product Use Among Low-Income Smokers	16
Perceptions of the Combining HIV Services and Microenterprise for Sustainable Recovery (CHIMES) Intervention for Sober House Residents in Tanzania: A Qualitative Study	16
How has the brain disease model of addiction contributed to tobacco control?	15
Editorial Board	15
Causally Linkage of Adolescent Behavioral Anomalies to Prenatal Opioid Exposure	15
Pregnenolone Effects on Cocaine Use in Individuals with Cocaine Use Disorder	15
Stakeholder preferences for supervised consumption site design, staff, and ancillary services: A scoping review of feasibility studies	15
Impacts of impaired control and pharmacological criteria for lifetime alcohol use disorder on relationships between drinking and problems	15
Trends in poisonings involving ketamine in the United States, 2019–2023	15
Associations between cannabis use, opioid misuse and severe psychological distress in adolescents: A cross-sectional school-based study	15
Deficits in consummatory reward relate to severity of cocaine use	15
Real-World Abuse-Related Data for a Schedule Ii Serdexmethylphenidate and Dexmethylphenidate (SDX/d-MPH) Drug Product Suggests Low Rates of Abuse	15
Differences in Methamphetamine Use and Self-Reported Impact by Gender and Sexual Orientation in a Multisite U.s. Cohort of People with Hiv in Care	15
Trends in overdose deaths involving gabapentinoids and Z-drugs in the United States	15
Mirtazapine reduces hypothetical methamphetamine demand in humans	15
Identifying biomarkers of drug use recurrence using wearable device technologies and phone applications	15
Prenatal alcohol exposure and offspring subsequent alcohol use: A systematic review	15
A Randomized Controlled Six-Way Crossover Study to Characterize the Nicotine Pharmacokinetics of a Novel Oral Nicotine Pouch Product	15
Editorial Board	15
School party culture as a driver of cocaine use among Norwegian adolescents: A cross-classified multilevel analysis	15
Associations of sex-related steroid hormones and proteins with alcohol dependence: A United Kingdom Biobank study	15
Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns	15
Structural indices of brain aging in methamphetamine use disorder	15
Differences in tobacco smoking and alcohol consumption among 57,757 women from early to late pregnancy: A state-representative study in Queensland, Australia	15
Editorial Board	14
Oud Treatment, Harm Reduction Service Engagement, and Sexually Transmitted Infection Risk Among Men and Women who Use Illicit Opioids in New York City	14
An investigation of multimodal predictors of adolescent alcohol initiation	14
Different brain oxidative and neuroinflammation status in rats during prolonged abstinence depending on their ethanol relapse-like drinking behavior: Effects of ethanol reintroduction	14
Assessing inequities in buprenorphine treatment across the care cascade	14
Trajectories of delay discounting and smoking from adolescence to young adulthood	14
Impact of reduced nicotine content on behavioral economic measures of cigarette reinforcement in adolescents who smoke cigarettes	14
Clustering of risk behaviors and classification performance in modeling adolescent risk: The example of the association between E-cigarette use and cigarette smoking	14
Awareness of drug supply changes and uptake of fentanyl testing services among people who use drugs in Kampala, Uganda	14
Alcohol use in firefighters: A network model of behaviors and transdiagnostic risk	14
Factors Associated With Risk for Cannabis Use Disorder Among Adults Using Medical Marijuana in Florida	14
Group behavioral activation with and without a smartphone app in intensive outpatient treatment for substance use disorder: A three-arm randomized controlled trial	14
The socioeconomic, health, and family situation of adult siblings of patients with substance use diagnosis: A descriptive registry study	14
Assessment of substance exposures in nail clipping samples: A systematic review	14
Prospective association between screen use modalities and substance use experimentation in early adolescents	14
CAREGIVING AND COPING: ALCOHOL USE DURING THE PANDEMIC IN NEW YORK CITY	14
Cross sectional multi-sample study of nonfatal overdose in adolescents and young adults in the fentanyl era	14
Violence, policing, and systemic racism as structural barriers to substance use treatment amongst women sex workers who use drugs: Findings of a community-based cohort in Vancouver, Canada (2010–2019)	14
Effects of very low nicotine cigarettes, e-cigarettes, and nicotine patches on daily own-cigarette abstinence in a randomized controlled switching trial	14
Protecting historically marginalized groups or targeted marketing? A computational analysis of individuals engaging with public and protected cigar-branded tweets	14
Secondhand electronic cigarette aerosol in vehicles impacts indoor air quality	14
Small Business Program: Implementation of a Technological Solution to Support Treatment for Opioid Use Disorder in the Primary Care Setting	13
Trends of Prenatal Substance Exposure: A 10 Year Evaluation of Umbilical Cord Test Outcomes	13
Perceptions of Overdose Response Hotlines Among a Sample of People in Treatment for Substance Use Disorder	13
Daily impulsivity is associated with alcohol use and problems via coping motives, but not enhancement motives	13
Editorial Board	13
Positive Methamphetamine Urinalysis Result During Treatment Intake is Not Associated With Worst Treatment Outcomes Amongst Opioid Users Initiating Medication-Assisted Opioid Treatment in Rural Communi	13
Exploring Long-Term Trajectories of Quality of Life for People who are Treated With Methadone	13
Gender Differences in Smoking Dependence Motives	13
Drug Decriminalization in the United States: Emerging Models, Implementation Experiences and Implications for Health and Racial Equity	13
Emotion Dysregulation Fully Mediates the Relationship between Stress and Impulsivity in Inpatients With Co-Occurring Substance Use and Mental Health Disorders	13
A national study on pregaming motives, frequency, consumption, and negative alcohol consequences among university students in the United States	13
FcGBP and VCAM-1 are ponderable biomarkers for differential diagnosis of alcoholic liver cirrhosis	13
WORKSHOP: NEW APPROACHES TO CULTURALLY APPROPRIATE TREATMENT AND RESEARCH	13
Changes in Opioid Agonist Treatment Initiation Following Voluntary and Mandatory Prescription Drug Monitoring Program Implementation: A Time Series Analysis	13
Health Justice Coordination for Increased Access to Health and Social Services for People With Drug Use Disorders in Contact With the Criminal Justice System	13
High Threshold Prescribing Practices Associated With Increased Termination of Care: Results From a Survey of Michigan Buprenorphine Prescribers	13
Incentivized Collaborative Care to Disseminate Contingency Management via Buprenorphine Treatment	13
U.S. older adults’ heroin and psychostimulant use treatment admissions, 2012–2019: Sociodemographic and clinical characteristics	13
Intergenerational transmission of tobacco smoking: The role of the child’s behavioral difficulties. Data from the Danish National Birth cohort (DNBC)	13
Hours high as a proxy for marijuana use quantity in intensive longitudinal designs	13
Access to Medications for Opioid Use Disorders: A Multi-Site Comparison of Qualitative Evidence With Stakeholders	13
Stimulant use, HIV, and immune dysregulation among sexual minority men	12
Editorial Board	12
Program Descriptions of the “Multi-Sector and Multi-Level Community-Driven Approaches to Remove Structural Racism and Overdose Deaths in Black Indianapolis Communities” (MACRO-B) Project	12
Trajectories of Medical Use of Prescription Opioids and Longitudinal Associations With Substance Use Disorder Symptoms in Adulthood (Ages 35-60)	12
Alcohol Use and Racial Discrimination in Later Generations of Latine Immigrants	12
10 Hz Excited DLPFC, but Not 1 Hz Inhibited Mofc Induced Smoking Cessation: A Randomized Repetitive Transcranial Magnetic Stimulation Trial	12
Heightened Insula Signal but Reduced Interoceptive Awareness is Linked to Relapse in Opioid Use Disorder: Preliminary Findings	12
Open Board	12
NEUROLOGICAL AND BEHAVIORAL CHANGES 6 MONTHS AFTER GASTRIC SLEEVE METABOLIC SURGERY	12
Depressive symptoms predict cannabis vaping initiation among young adults	12
Do Dual Users Vape When Attempting to Quit Smoking? The Association Between E-Cigarette Use and Concurrent Cigarette Cessation-Related Outcomes in a Prospective Natural History Study	12
Intimate partner violence is related to future alcohol use among a nationwide sample of LGBTQIA+ people: Results from The PRIDE Study	12
Predictors of non-fatal overdose in the month following discharge From residential treatment	12
Examining Engagement in Contingency Management for Smoking Cessation Among Homeless-Experienced Veterans: The Role of Dual Diagnosis	12
Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal Survey	12
Development and Validation of Machine-Learning Algorithms Predicting Retention, Overdoses, and All-Cause Mortality Among US Military Veterans Treated with Buprenorphine for Opioid Use Disorder	12
Emerging Hot Spot Analyses for Rapid Actionable Data for Opioid Response in Kentucky (RADOR-KY)	12
An updated view on the influence of initial opioid prescription characteristics on long-term opioid use among opioid naïve patients	12
Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats	12
FACTORS LINKED WITH PSYCHOLOGICAL DISTRESS IN A DIVERSE SAMPLE OF SUBSTANCE-USING ADULTS IN THE SOUTHEASTERN U.S.	12
Mesocorticolimbic Activation is Associated With Abstinence From Cannabis in a Pilot Trial of Varenicline for Cannabis Use Disorder	12
Integrating MOUD in Non-Medical Community Organizations: Better Together MOUD (BT-MOUD)	12
HARM REDUCTION SUPPLY DISTRIBUTION VIA VENDING MACHINES: 6-MONTH OUTCOMES FOR A CALIFORNIA VETERANS AFFAIRS HEALTH CARE SYSTEM	12
The Role of Substance Use on ART Adherence Among Black People With HIV	12
Lifetime and 30-Day Drug Use Associated With Higher by FTND Scores	12
Assessing the Association Between Increased Student-Adult Connections, Perceptions of School, and Substance Misuse Rates Among Justice-Involved Adolescents	12